Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study

English version České info

Background:
A major impediment to tuberculosis control in Africa is the difficulty in diagnosing active tuberculosis (TB), particularly in the context of HIV infection. We hypothesized that a unique host blood RNA transcriptional signature would distinguish TB from other diseases (OD) in HIV-infected and -uninfected patients, and that this could be the basis of a simple diagnostic test.

Methods and Findings:
Adult case-control cohorts were established in South Africa and Malawi of HIV-infected or -uninfected individuals consisting of 584 patients with either TB (confirmed by culture of Mycobacterium tuberculosis [M.TB] from sputum or tissue sample in a patient under investigation for TB), OD (i.e., TB was considered in the differential diagnosis but then excluded), or healthy individuals with latent TB infection (LTBI). Individuals were randomized into training (80%) and test (20%) cohorts. Blood transcriptional profiles were assessed and minimal sets of significantly differentially expressed transcripts distinguishing TB from LTBI and OD were identified in the training cohort. A 27 transcript signature distinguished TB from LTBI and a 44 transcript signature distinguished TB from OD. To evaluate our signatures, we used a novel computational method to calculate a disease risk score (DRS) for each patient. The classification based on this score was first evaluated in the test cohort, and then validated in an independent publically available dataset (GSE19491).

In our test cohort, the DRS classified TB from LTBI (sensitivity 95%, 95% CI [87–100]; specificity 90%, 95% CI [80–97]) and TB from OD (sensitivity 93%, 95% CI [83–100]; specificity 88%, 95% CI [74–97]). In the independent validation cohort, TB patients were distinguished both from LTBI individuals (sensitivity 95%, 95% CI [85–100]; specificity 94%, 95% CI [84–100]) and OD patients (sensitivity 100%, 95% CI [100–100]; specificity 96%, 95% CI [93–100]).

Limitations of our study include the use of only culture confirmed TB patients, and the potential that TB may have been misdiagnosed in a small proportion of OD patients despite the extensive clinical investigation used to assign each patient to their diagnostic group.

Conclusions:
In our study, blood transcriptional signatures distinguished TB from other conditions prevalent in HIV-infected and -uninfected African adults. Our DRS, based on these signatures, could be developed as a test for TB suitable for use in HIV endemic countries. Further evaluation of the performance of the signatures and DRS in prospective populations of patients with symptoms consistent with TB will be needed to define their clinical value under operational conditions.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study. PLoS Med 10(10): e32767. doi:10.1371/journal.pmed.1001538
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001538

Souhrn

Zdroje

1. MunthaliL, MwaunguluJN, MunthaliK, BowieC, CrampinAC (2006) Using tuberculosis suspects to identify patients eligible for antiretroviral treatment. Int J Tuberc Lung Dis 10: 199–202.

2. LawnSD, WoodR (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 204 Suppl 4: S1159–S1167.

3. AabyeMG, RavnP, PrayGodG, JeremiahK, MugomelaA, et al. (2009) The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 4: e4220 doi:10.1371/journal.pone.0004220

4. ChamieG, LuetkemeyerA, Walusimbi-NantezaM, OkweraA, WhalenCC, et al. (2010) Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis 14: 1295–1302.

5. KwanCK, ErnstJD (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24: 351–376.

6. VittorAY, GarlandJM, SchlossbergD (2011) Improving the diagnosis of tuberculosis: From QuantiFERON to new techniques to diagnose tuberculosis infections. Curr HIV/AIDS Rep 8: 153–163.

7. WoodR, MaartensG, LombardCJ (2000) Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 23: 75–80.

8. PerkinsMD, CunninghamJ (2007) Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196 Suppl 1: S15–27.

9. LangeC, PaiM, DrobniewskiF, MiglioriGB (2009) Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 33: 1250–1253.

10. RangakaMX, GideonHP, WilkinsonKA, PaiM, Mwansa-KambafwileJ, et al. (2012) Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. Eur Respir J 39: 163–171.

11. BoehmeCC, NabetaP, HillemannD, NicolMP, ShenaiS, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005–1015.

12. BoehmeCC, NicolMP, NabetaP, MichaelJS, GotuzzoE, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495–1505.

13. PronykPM, KahnK, HargreavesJR, TollmanSM, CollinsonM, et al. (2004) Undiagnosed pulmonary tuberculosis deaths in rural South Africa. Int J Tuberc Lung Dis 8: 796–799.

14. CoxJA, LukandeRL, LucasS, NelsonAM, Van MarckE, et al. (2010) Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 12: 183–194.

15. AnsariNA, KombeAH, KenyonTA, HoneNM, TapperoJW, et al. (2002) Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Int J Tuberc Lung Dis 6: 55–63.

16. ChaussabelD, PascualV, BanchereauJ (2010) Assessing the human immune system through blood transcriptomics. BMC Biol 8: 84.

17. van 't VeerLJ, DaiH, van de VijverMJ, HeYD, HartAA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536.

18. RamiloO, AllmanW, ChungW, MejiasA, ArduraM, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109: 2066–2077.

19. MaertzdorfJ, WeinerJ, MollenkopfHJ, NetworkT, BauerT, et al. (2012) Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 109: 7853–7858.

20. LeshoE, ForestieroFJ, HirataMH, HirataRD, CeconL, et al. (2011) Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb) 91: 390–399.

21. MaertzdorfJ, OtaM, RepsilberD, MollenkopfHJ, WeinerJ, et al. (2011) Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS ONE 6: e26938 doi:10.1371/journal.pone.0026938

22. MaertzdorfJ, RepsilberD, ParidaSK, StanleyK, RobertsT, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15–22.

23. MistryR, CliffJM, ClaytonCL, BeyersN, MohamedYS, et al. (2007) Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 195: 357–365.

24. JacobsenM, RepsilberD, GutschmidtA, NeherA, FeldmannK, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis.. J Mol Med (Berl) 85: 613–621.

25. BerryMP, GrahamCM, McNabFW, XuZ, BlochSA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973–977.

26. LuC, WuJ, WangH, WangS, DiaoN, et al. (2011) Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One 6: e24290 doi/10.1371/journal.pone.0024290.

27. WHO (2011) Global tuberculosis control: WHO report. Geneva: WHO.

28. KranzerK, van SchaikN, KarmueU, MiddelkoopK, SebastianE, et al. (2011) High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. PLoS One 6: e25244 doi/10.1371/journal.pone.0025244.

29. CrampinAC, FloydS, MwaunguluF, BlackG, NdhlovuR, et al. (2001) Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence. Int J Tuberc Lung Dis 5: 994–999.

30. HussainR, KaleemA, ShahidF, DojkiM, JamilB, et al. (2002) Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264: 95–108.

31. FrankenKL, HiemstraHS, van MeijgaardenKE, SubrontoY, den HartighJ, et al. (2000) Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 18: 95–99.

32. Ripley BD (1987) Stochastic simulation. New York: Wiley & Sons.

33. BenjaminiY, HochbergY (1995) Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289–300.

34. ZouH, HastieT (2005) Regularization and variable selection via the elastic net. J R Stat Soc Series B Stat Methodol 67: 301–320.

35. JoostenSA, GoemanJJ, SutherlandJS, OpmeerL, de BoerKG, et al. (2012) Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun 13: 71–82.

36. ElderingE, SpekCA, AbersonHL, GrummelsA, DerksIA, et al. (2003) Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 31: e153.

37. WangY, ZhengD, TanQ, WangMX, GuLQ (2011) Nanopore-based detection of circulating microRNAs in lung cancer patients. Nat Nanotechnol 6: 668–674.

38. LaromaineA, KohL, MurugesanM, UlijnRV, StevensMM (2007) Protease-triggered dispersion of nanoparticle assemblies. J Am Chem Soc 129: 4156–4157.

39. LoweSB, DickJA, CohenBE, StevensMM (2012) Multiplex sensing of protease and kinase enzyme activity via orthogonal coupling of quantum dot-peptide conjugates. ACS Nano 6: 851–857.

40. MorrowTJ, LiM, KimJ, MayerTS, KeatingCD (2009) Programmed assembly of DNA-coated nanowire devices. Science 323: 352.